Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 26.31B | 23.08B | 21.26B | 19.52B | 19.28B |
Gross Profit | 17.23B | 15.10B | 5.91B | 5.19B | 5.14B |
EBITDA | 3.97B | 3.45B | 2.81B | 2.91B | 2.41B |
Net Income | 1.96B | 1.86B | 1.59B | 1.76B | 1.30B |
Balance Sheet | |||||
Total Assets | 38.14B | 32.06B | 31.46B | 27.14B | 27.94B |
Cash, Cash Equivalents and Short-Term Investments | 3.38B | 4.11B | 3.36B | 3.11B | 2.96B |
Total Debt | 10.15B | 6.48B | 6.86B | 6.36B | 6.68B |
Total Liabilities | 26.36B | 21.34B | 19.06B | 18.66B | 22.34B |
Stockholders Equity | 11.62B | 10.56B | 11.21B | 7.44B | 4.64B |
Cash Flow | |||||
Free Cash Flow | 2.76B | 2.80B | 2.00B | 1.82B | 508.00M |
Operating Cash Flow | 3.92B | 3.76B | 2.70B | 2.28B | 985.00M |
Investing Cash Flow | -5.27B | -541.00M | -548.00M | -14.00M | -2.08B |
Financing Cash Flow | 695.00M | -2.19B | -2.06B | -1.99B | 1.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £2.71B | 17.97 | -23.92% | 1.11% | 10.36% | 32.77% | |
75 Outperform | £2.09B | 49.45 | 4.71% | 2.01% | -0.68% | -78.93% | |
75 Outperform | £1.51B | 38.67 | 11.62% | 1.86% | 8.00% | 674.47% | |
74 Outperform | £5.47B | 22.13 | 49.75% | 0.74% | 3.34% | 481.76% | |
73 Outperform | $80.68B | 31.75 | 0.46% | 14.70% | 3.76% | ||
66 Neutral | £55.08B | 28.95 | 17.85% | 1.62% | 14.01% | 6.03% | |
58 Neutral | $1.34B | 4.24 | -2.93% | 7.38% | 3.67% | -51.13% |